These data suggest a potential function for IL-31 in regulating immune responses and inflammation through modulating antigen-presenting cells or more directly T cell themselves and implicate IL-31/IL-31R signalling as a negative regulatory pathway that specifically could limit type 2 inflammation, which is mainly protecting against osteoporosis [45]. Here, IL31 is linked to osteoporosis.